Arginine News and Research

RSS
Arginine is considered a semi-essential amino acid because even though the body normally makes enough of it, supplementation is sometimes needed. For example, people with protein malnutrition, excessive ammonia production, excessive lysine intake, burns, infections, peritoneal dialysis, rapid growth, urea synthesis disorders, or sepsis may not have enough arginine. Symptoms of arginine deficiency include poor wound healing, hair loss, skin rash, constipation, and fatty liver.

Arginine changes into nitric oxide, which causes blood vessel relaxation (vasodilation). Early evidence suggests that arginine may help treat medical conditions that improve with vasodilation, such as chest pain, clogged arteries (called atherosclerosis), coronary artery disease, erectile dysfunction, heart failure, intermittent claudication/peripheral vascular disease, and blood vessel swelling that causes headaches (vascular headaches). Arginine also triggers the body to make protein and has been studied for wound healing, bodybuilding, enhancement of sperm production (spermatogenesis), and prevention of wasting in people with critical illnesses.

Arginine hydrochloride has a high chloride content and has been used to treat metabolic alkalosis. This use should be under the supervision of a qualified healthcare professional.
FDA approves MedImmune's FluMist Quadrivalent vaccine

FDA approves MedImmune's FluMist Quadrivalent vaccine

ARCA biopharma receives method patent for treatment with bucindolol based on genetic targeting

ARCA biopharma receives method patent for treatment with bucindolol based on genetic targeting

KCC Director recognized for distinguished contributions to cancer care

KCC Director recognized for distinguished contributions to cancer care

Arginine may reactivate T-cells in patients with glioblastoma

Arginine may reactivate T-cells in patients with glioblastoma

Arginase-2 enzyme plays a major role in diabetic nephropathy

Arginase-2 enzyme plays a major role in diabetic nephropathy

Pivotal pediatric clinical study comparing Q/LAIV to FluMist meets primary endpoint

Pivotal pediatric clinical study comparing Q/LAIV to FluMist meets primary endpoint

Cyclic proteins transport drugs faster

Cyclic proteins transport drugs faster

Favorable top-line results from Aeterna Zentaris' AEZS-130 Phase 3 study on AGHD

Favorable top-line results from Aeterna Zentaris' AEZS-130 Phase 3 study on AGHD

Study: AAKG supplementation has no significant impact on increased blood flow

Study: AAKG supplementation has no significant impact on increased blood flow

Polaris initiates ADI-PEG 20 Phase 3 trial in hepatocellular carcinoma

Polaris initiates ADI-PEG 20 Phase 3 trial in hepatocellular carcinoma

Natural recycling system, PPAR agonists can help protect children with heart defects

Natural recycling system, PPAR agonists can help protect children with heart defects

Aeterna Zentaris completes AEZS-130 Phase 3 study for diagnosis of AGHD

Aeterna Zentaris completes AEZS-130 Phase 3 study for diagnosis of AGHD

FDA files MedImmune's sBLA for quadrivalent intranasal nasal influenza vaccine, FluMist

FDA files MedImmune's sBLA for quadrivalent intranasal nasal influenza vaccine, FluMist

Female cancer survivors benefit from natural nutritional supplement

Female cancer survivors benefit from natural nutritional supplement

Patch-clamp recording reveals subtle differences between two neurotransmitter-gated ion channels

Patch-clamp recording reveals subtle differences between two neurotransmitter-gated ion channels

ARCA plans to expand development program for Gencaro in atrial fibrillation

ARCA plans to expand development program for Gencaro in atrial fibrillation

Polaris' ADI-PEG 20 exhibits potential against AML, GBM and bladder cancer

Polaris' ADI-PEG 20 exhibits potential against AML, GBM and bladder cancer

Polaris initiates ADI-PEG 20 Phase 2 trial in patients with malignant mesothelioma

Polaris initiates ADI-PEG 20 Phase 2 trial in patients with malignant mesothelioma

First study to show link between AVPR1A gene variants with listening to music

First study to show link between AVPR1A gene variants with listening to music

Scientists determine protein structure that delivers genetic material of HIV to human cells

Scientists determine protein structure that delivers genetic material of HIV to human cells